The Inhibitory Effects of Maclurin on Fatty Acid Synthase and Adipocyte Differentiation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25168579 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ji Young Hwang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Smart Green Technology Engineering, Pukyong National University, Busan 48513, Republic of Korea. Hauptthemen laut MEDLINE: 3T3-L1 Cells, Adipocytes, Adipogenesis, Cell Differentiation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, National Research Foundation of Korea (NRF) grant funded by the Ministry of Education.
Abstract (Originalsprache)
Obesity is a complex health condition characterized by excessive adipose tissue accumulation, leading to significant metabolic disturbances such as insulin resistance and cardiovascular diseases. Fatty acid synthase (FAS), a key enzyme in lipogenesis, has been identified as a potential therapeutic target for obesity due to its role in adipocyte differentiation and lipid accumulation. This study employed a multidisciplinary approach involving in silico and in vitro analyses to investigate the anti-adipogenic properties of maclurin, a natural phenolic compound derived from Morus alba. Using SwissDock software (ChEMBL version 23), we predicted protein interactions and demonstrated a high probability (95.6%) of maclurin targeting FAS, surpassing the interaction rates of established inhibitors like cerulenin. Docking simulations revealed maclurin’s superior binding affinity to FAS, with a binding score of −7.3 kcal/mol compared to −6.7 kcal/mol for cerulenin. Subsequent in vitro assays confirmed these findings, with maclurin effectively inhibiting FAS activity in a concentration-dependent manner in 3T3-L1 adipocytes, without compromising cell viability. Furthermore, maclurin treatment resulted in significant reductions in lipid accumulation and the downregulated expression of critical adipogenic genes such as PPARγ, C/EBPα, and FAS, indicating the suppression of adipocyte differentiation. Maclurin shows potential as a novel FAS inhibitor with significant anti-adipogenic effects, offering a promising therapeutic avenue for the treatment and prevention of obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Smart Green Technology Engineering, Pukyong National University, Busan 48513, Republic of Korea.
- Department of Food Science and Nutrition, Pukyong National University, Busan 48513, Republic of Korea.
- Marine Integrated Biomedical Technology Center, The National Key Research Institutes, Pukyong National University, Busan 48513, Republic of Korea.
ORCID-Profile: Jae-Il Kim
Förderung
- National Research Foundation of Korea
- National Research Foundation of Korea (NRF) grant funded by the Ministry of Education
Zitieren
APA
Hwang, J. Y., Jeong, H. H., Baek, J., Lee, J., Ryu, H., Kim, J. I., & Lee, B. (2024). The Inhibitory Effects of Maclurin on Fatty Acid Synthase and Adipocyte Differentiation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25168579
Vancouver
Hwang JY, Jeong HH, Baek J, Lee J, Ryu H, Kim JI, et al. The Inhibitory Effects of Maclurin on Fatty Acid Synthase and Adipocyte Differentiation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25168579
BibTeX
@article{Hwang2024,
author = {Hwang, Ji Young and Jeong, Hyeon Hak and Baek, Jiwon and Lee, Jiyun and Ryu, Heeyeon and Kim, Jae-Il and Lee, Bonggi},
title = {The Inhibitory Effects of Maclurin on Fatty Acid Synthase and Adipocyte Differentiation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25168579}
}
EUVIMED